Cancer Treatment Reviews
Volume 26, Issue 3 , Pages 205-227, June 2000

Selective oestrogen receptor modifiers (SERMs) and breast cancer therapy

  • E.A. Lien

      Affiliations

    • Department of Biochemical Endocrinology, Section of Oncology, Haukeland University Hospital, Bergens, N-5021, Norway
    • ,
  • P.E. Lønning

      Affiliations

    • Department of Medicine, Section of Oncology, Haukeland University Hospital, Bergens, N-5021, Norway

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

PII: S0305-7372(99)90162-7

doi:10.1053/ctrv.1999.0162

Cancer Treatment Reviews
Volume 26, Issue 3 , Pages 205-227, June 2000

Article Tools